Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.
about
Emerging concepts in pancreatic cancer medicine: targeting the tumor stromaRole of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlightTargeting ECM Disrupts Cancer ProgressionBreaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyFluorescent imaging of cancerous tissues for targeted surgery.Oncolytic viral therapy for pancreatic cancer: current research and future directionsThe pancreas cancer microenvironmentA Facile Approach to Functionalize Cell Membrane-Coated NanoparticlesWhy don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionEnzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinomaCurrent and future systemic treatment options in metastatic pancreatic cancer.New option for the initial management of metastatic pancreatic cancer?Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronanRole of versican, hyaluronan and CD44 in ovarian cancer metastasis.Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic TumorsBiological rationale for the design of polymeric anti-cancer nanomedicines.Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidaseBinding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance.CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerInterstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase.Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface.Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells.Effects of anti-CD44 monoclonal antibody IM7 carried with chitosan polylactic acid-coated nano-particles on the treatment of ovarian cancerHyaluronan: a simple polysaccharide with diverse biological functions.Role of pancreatic stellate cells in chemoresistance in pancreatic cancer.The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.Therapeutic targeting of hyaluronan in the tumor stroma.Brief overview of selected approaches in targeting pancreatic adenocarcinoma.Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.The extracellular matrix modulates the hallmarks of cancer.Stromal biology and therapy in pancreatic cancer: a changing paradigm.Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second lookThe 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer.
P2860
Q24627664-98806794-503A-4100-A8DB-D5B191DB61F2Q26766075-A144F10A-0632-4E2F-9C37-FBA3458109D7Q26779300-509F25A6-AB47-4919-A266-707322570A4DQ26784055-C4C5FC34-AF53-404B-9CEA-4182E8C1197DQ26830905-8C0E98F2-2DA5-4EF2-A430-A3F54DBEFDFAQ27011439-90FD487A-D81B-4C91-AC89-9B2E513DFFAFQ27026705-4A54EA89-3F96-4C66-8258-72499A96876BQ28833663-2289E3ED-DBD7-49F4-B13C-6DEFE8086501Q29614274-7E56035F-5BBB-4D45-B46D-F1211AF58E37Q29616287-348C36F5-D697-4A0D-829E-574EB6B7A5A5Q33948033-D368F763-9BB6-4BC4-BF81-3DCEBF4ADCB7Q34000969-EE6E864F-A373-43EB-B50A-DBF9E9E1EE80Q34145464-E8F1A4E5-5A24-4E53-92FA-E338928079D5Q34874835-9CD7E8DD-BEB7-4DE0-AE69-1663FFCFC15AQ36031608-DA2341E4-5FFF-433C-96F7-A3EA493BD638Q36160333-3EED8B1C-8165-4694-A1A5-DE4A3EF9DBF0Q36218165-E6091B55-9F5A-4742-AD28-BBCCE3E970EDQ36229271-54F439CA-C454-491D-98D3-96369FB60D8CQ36285897-E83F759C-EA65-4748-AD1D-62ED829B6121Q36550798-0C1E61B3-B439-43AD-8462-4146D51FDDCBQ36557915-7EEE8855-6F43-42E8-BB91-2A452FB1DD01Q36757056-2BD04880-4DA9-43FC-AAC6-22EE5BC0EC09Q36867481-B8351B90-4851-481C-B391-A447F5196A84Q37049583-76F7FEA4-C89E-48C5-B190-DCD03C113E25Q37081606-0C4523E6-F83E-4B22-97EF-FBA91A9F11F1Q37119287-D2ACB532-A95D-4DF4-84CA-85BC44874646Q37460389-E90196EB-10D0-4DDF-A0C4-A828C5C4048CQ37575305-484DD76A-9581-4F21-9387-467B5740778FQ37594246-9B42DB38-F461-4E3A-9F39-E44D34A3D090Q37649833-D3B8F049-0B91-4A13-A6A7-86AD0D63000DQ37705462-568200DA-5F33-4B27-A552-DB11B5E814F3Q37729238-51F4EB07-451C-4F29-BC68-D91A53FE89B2Q38161392-A4002243-1AFA-421B-9137-5A9D224B87C4Q38199723-D957F148-EA17-4188-BBD5-0209AC442ADAQ38217591-E3170E9D-E34B-44FA-BE89-FD06C6887599Q38260975-D6065074-AE81-4CC3-AEF1-4F983D8F55C1Q38266276-46FD2BB1-5CAA-45A8-A898-B8FDC267365CQ38494338-75B9CC2E-EAAD-4782-80DC-AA2F98819FCEQ38880513-58025DCE-0BA8-4110-B2ED-8D049B1865CDQ38981265-DDBD1A86-4724-4467-9A96-D0D8151C553E
P2860
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Enzymatic depletion of tumor h ...... in preclinical animal models.
@en
Enzymatic depletion of tumor h ...... in preclinical animal models.
@nl
type
label
Enzymatic depletion of tumor h ...... in preclinical animal models.
@en
Enzymatic depletion of tumor h ...... in preclinical animal models.
@nl
prefLabel
Enzymatic depletion of tumor h ...... in preclinical animal models.
@en
Enzymatic depletion of tumor h ...... in preclinical animal models.
@nl
P2093
P1476
Enzymatic depletion of tumor h ...... in preclinical animal models.
@en
P2093
Barry J Sugarman
Curtis B Thompson
Gregory I Frost
H Michael Shepard
Louis H Bookbinder
Patrick M O'Connor
Ping Jiang
Robert J Connor
Ryan J Osgood
Salam Kadhim
P304
P356
10.1158/1535-7163.MCT-10-0470
P577
2010-10-26T00:00:00Z